The expression of VEGF-A is down regulated in peripheral blood mononuclear cells of patients with secondary progressive multiple sclerosis.
<h4>Background</h4>Most patients with relapsing-remitting multiple sclerosis (RRMS) eventually enter a secondary progressive (SPMS) phase, characterized by increasing neurological disability. The mechanisms underlying transition to SPMS are unknown and effective treatments and biomarkers...
Main Authors: | Ellen Iacobaeus, Petra Amoudruz, Mikael Ström, Mohsen Khademi, Lou Brundin, Jan Hillert, Ingrid Kockum, Vivianne Malmström, Tomas Olsson, Emma Tham, Fredrik Piehl |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2011-05-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21573104/?tool=EBI |
Similar Items
-
Confounding effect of blood volume and body mass index on blood neurofilament light chain levels
by: Ali Manouchehrinia, et al.
Published: (2020-01-01) -
The Temporal Retinal Nerve Fiber Layer Thickness Is the Most Important Optical Coherence Tomography Estimate in Multiple Sclerosis
by: Ulrika Birkeldh, et al.
Published: (2017-12-01) -
Maternal immune characteristics and innate immune responses in the child in relation to allergic disease
by: Amoudruz, Petra
Published: (2008) -
Peripheral blood mononuclear cells extracts VEGF protein levels and VEGF mRNA: Associations with inflammatory molecules in a healthy population.
by: Vesna Gorenjak, et al.
Published: (2019-01-01) -
Correction: Peripheral blood mononuclear cells extracts VEGF protein levels and VEGF mRNA: Associations with inflammatory molecules in a healthy population.
by: Vesna Gorenjak, et al.
Published: (2019-01-01)